Steffen Ormanns

3.5k total citations · 1 hit paper
70 papers, 1.6k citations indexed

About

Steffen Ormanns is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steffen Ormanns has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 24 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steffen Ormanns's work include Pancreatic and Hepatic Oncology Research (39 papers), Cancer Genomics and Diagnostics (21 papers) and Neuroendocrine Tumor Research Advances (11 papers). Steffen Ormanns is often cited by papers focused on Pancreatic and Hepatic Oncology Research (39 papers), Cancer Genomics and Diagnostics (21 papers) and Neuroendocrine Tumor Research Advances (11 papers). Steffen Ormanns collaborates with scholars based in Germany, Austria and United States. Steffen Ormanns's co-authors include Stephan Krüger, Volker Heinemann, Stefan Boeck, Michael Haas, Thomas Kirchner, Michael von Bergwelt‐Baildon, Jan DʼHaese, Stefan Endres, C. Benedikt Westphalen and Sebastian Kobold and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Steffen Ormanns

64 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in cancer immunotherapy 2019 – latest trends

2019 400 citations Stephan Krüger, Stefan Endres et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steffen Ormanns Germany	20	1.0k	486	434	428	315	70	1.6k
Antonella Argentiero Italy	23	794 0.8×	596 1.2×	427 1.0×	406 0.9×	326 1.0×	48	1.6k
Rahul Ladwa Australia	16	986 1.0×	525 1.1×	241 0.6×	519 1.2×	365 1.2×	93	1.7k
Sreya Bagchi United States	10	984 1.0×	512 1.1×	186 0.4×	778 1.8×	370 1.2×	14	1.8k
Francesco Pantano Italy	25	993 1.0×	861 1.8×	577 1.3×	307 0.7×	549 1.7×	109	2.1k
Salvatore Pisconti Italy	22	692 0.7×	502 1.0×	396 0.9×	154 0.4×	434 1.4×	97	1.7k
Cinzia Solinas Italy	28	1.7k 1.7×	421 0.9×	311 0.7×	1.0k 2.3×	445 1.4×	80	2.4k
Alex Chehrazi‐Raffle United States	11	869 0.8×	374 0.8×	171 0.4×	461 1.1×	331 1.1×	64	1.3k
Kim C. Ohaegbulam United States	14	1.2k 1.2×	416 0.9×	180 0.4×	884 2.1×	339 1.1×	19	1.8k
Taigo Kato Japan	27	633 0.6×	547 1.1×	270 0.6×	402 0.9×	307 1.0×	118	1.6k
Jon C. Jones United States	16	1.1k 1.1×	712 1.5×	246 0.6×	225 0.5×	165 0.5×	25	1.7k

Countries citing papers authored by Steffen Ormanns

Since Specialization

Citations

This map shows the geographic impact of Steffen Ormanns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Ormanns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Ormanns more than expected).

Fields of papers citing papers by Steffen Ormanns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Ormanns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Ormanns. The network helps show where Steffen Ormanns may publish in the future.

Co-authorship network of co-authors of Steffen Ormanns

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Ormanns. A scholar is included among the top collaborators of Steffen Ormanns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Ormanns. Steffen Ormanns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allawadhi, Prince, Ujjwal Mukund Mahajan, Elisabetta Goni, et al.. (2025). Diagnostic accuracy and Patient Derived Organoid (PDO) yield of 19G vs 22G Franseen needles for EUS-Guided biopsy in solid pancreatic lesions: A prospective comparative study. Pancreatology. 25(8). 1442–1449.

Günther, Michael, Arno Amann, Steffen Ormanns, et al.. (2025). Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies. npj Precision Oncology. 9(1). 116–116. 5 indexed citations

Ormanns, Steffen, et al.. (2025). Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients which is mitigated by postoperative antibiotics. British Journal of Cancer. 133(4). 574–581. 1 indexed citations

Bodogai, Monica, Bong Soo Park, Chen Chen, et al.. (2025). A distinct population of CD8+ T cells expressing CD39 and CD73 accumulates with age and supports cancer progression. Nature Aging. 5(10). 2055–2069. 1 indexed citations

Pichler, Renate, Laura S. Mertens, Francesco Del Giudice, et al.. (2025). FGFR1/3 Signaling as an Achilles’ Heel of Phenotypic Diversity in Urothelial Carcinoma. European Urology Oncology.

Heinrich, Kathrin, Laura Fischer, Enrico N. De Toni, et al.. (2023). Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. JCO Precision Oncology. 7(7). e2200650–e2200650. 1 indexed citations

Dorman, Klara, Stephan Krüger, Alexander Rupp, et al.. (2022). Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers. Journal of Cancer Research and Clinical Oncology. 149(6). 2463–2474. 8 indexed citations

Zhang, Danmei, Andreas Zimmermann, Pontus Mertsch, et al.. (2021). Rituximab Treatment of Hairy Cell Leukemia in a Patient with <b><i>Mycobacterium kansasii</i></b> Infection: A Case Report. Oncology Research and Treatment. 44(11). 637–640. 1 indexed citations

Metzger, Philipp, Sabrina V. Kirchleitner, Steffen Ormanns, et al.. (2020). Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer Immunology Immunotherapy. 69(10). 2101–2112. 14 indexed citations

10.

Armacki, Milena, Claudia Ruhland, André Lechel, et al.. (2020). Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice. Gastroenterology. 159(3). 1019–1035.e22. 57 indexed citations

11.

Volz, Yannic, Tobias Grimm, Steffen Ormanns, et al.. (2020). Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival. Urologic Oncology Seminars and Original Investigations. 39(5). 299.e15–299.e21. 2 indexed citations

12.

Chaloupka, Michael, Philipp Weinhold, Friedrich Jokisch, et al.. (2020). Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?. World Journal of Urology. 39(5). 1431–1438. 3 indexed citations

13.

Ormanns, Steffen. (2018). Personalisierte Krebsmedizin. Der Pathologe. 39(S2). 221–224.

14.

Ormanns, Steffen, Michael Haas, Stephan Krüger, et al.. (2017). Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research. BMC Cancer. 17(1). 374–374. 1 indexed citations

15.

Krüger, Stephan, Michael Haas, Axel Kleespies, et al.. (2017). Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer – A retrospective cohort study. Thrombosis Research. 157. 9–15. 41 indexed citations

16.

Krüger, Stephan, Michael Haas, Steffen Ormanns, et al.. (2016). Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 142(12). 2585–2591. 25 indexed citations

17.

Ormanns, Steffen, A. Altendorf-Hofmann, René Jackstadt, et al.. (2015). Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma. British Journal of Cancer. 113(10). 1460–1466. 21 indexed citations

18.

Ormanns, Steffen, Gerald Assmann, Simone Reu, et al.. (2014). ALK expression is absent in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 140(9). 1625–1628. 3 indexed citations

19.

Ormanns, Steffen, Volker Heinemann, Mitch Raponi, et al.. (2014). Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: Translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody. European Journal of Cancer. 50(11). 1891–1899. 29 indexed citations

20.

Boeck, Stefan, Jens T. Siveke, Steffen Ormanns, et al.. (2013). P-ERK, P-AKT and p53 as Tissue Biomarkers in Erlotinib-Treated Patients with Advanced Pancreatic Cancer: a Translational Subgroup Analysis From Aio-PK0104. Annals of Oncology. 24. iv12–iv12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact